NCT07071532View on ClinicalTrials.gov

A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

ABBV-932

Oral Capsule

DRUG

Itraconazole

Oral Capsule

Trial Locations (1)

60030

Acpru /Id# 276951, Grayslake

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY